An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA)
Clinical trial NCT00787917 · TERMINATED
Trial details
- NCT number
- NCT00787917
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-07-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.